Skip to main content
Equibles

STATE STREET CORP

Position in TRAW — Traws Pharma, Inc.

CIK 93751 BOSTON, MA
Back to TRAW Full portfolio

Position in TRAW

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$21,673
-$25,544 QoQ
Shares Held
25,802
0.0% QoQ
Ownership
0.168%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 34 holders
Holding Since
Mar 2021
17 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in TRAW Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. TRAW ranks #398 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in TRAW

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $21,673 25,802
2026-03-31 $47,217 25,802
2025-12-31 $29,156 25,802
2024-06-30 $27,040 60,090
2024-03-31 $53,317 52,790
2023-12-31 $39,592 52,790
2023-09-30 $37,480 52,790
2023-06-30 $62,292 52,790
2023-03-31 $38,536 52,790
2022-12-31 $34,313 52,790
2022-09-30 $46,455 52,790
2022-06-30 $69,682 52,790
2022-03-31 $92,717 50,390
2021-12-31 $128,494 50,390
2021-09-30 $192,993 50,390
2021-06-30 $797,573 115,090